Logo image of BTCM

BIT MINING LTD - SPON ADR (BTCM) Stock Fundamental Analysis

USA - NYSE:BTCM - US0554742090 - ADR

2.67 USD
+0.08 (+3.09%)
Last: 9/29/2025, 8:04:01 PM
2.66 USD
-0.01 (-0.37%)
After Hours: 9/29/2025, 8:04:01 PM
Fundamental Rating

3

BTCM gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 281 industry peers in the Software industry. The financial health of BTCM is average, but there are quite some concerns on its profitability. BTCM is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

BTCM had positive earnings in the past year.
In the past year BTCM has reported a negative cash flow from operations.
In the past 5 years BTCM reported 4 times negative net income.
In the past 5 years BTCM always reported negative operating cash flow.
BTCM Yearly Net Income VS EBIT VS OCF VS FCFBTCM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

BTCM has a better Return On Assets (13.98%) than 91.10% of its industry peers.
Looking at the Return On Equity, with a value of 21.22%, BTCM belongs to the top of the industry, outperforming 87.54% of the companies in the same industry.
Industry RankSector Rank
ROA 13.98%
ROE 21.22%
ROIC N/A
ROA(3y)-71.39%
ROA(5y)-56.06%
ROE(3y)-133.77%
ROE(5y)-97.68%
ROIC(3y)N/A
ROIC(5y)N/A
BTCM Yearly ROA, ROE, ROICBTCM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

Looking at the Profit Margin, with a value of 36.67%, BTCM belongs to the top of the industry, outperforming 93.24% of the companies in the same industry.
Looking at the Gross Margin, with a value of 9.07%, BTCM is doing worse than 84.34% of the companies in the same industry.
BTCM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 36.67%
GM 9.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y179.81%
GM growth 5YN/A
BTCM Yearly Profit, Operating, Gross MarginsBTCM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

5

2. Health

2.1 Basic Checks

BTCM does not have a ROIC to compare to the WACC, probably because it is not profitable.
BTCM has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BTCM has been increased compared to 5 years ago.
BTCM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BTCM Yearly Shares OutstandingBTCM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
BTCM Yearly Total Debt VS Total AssetsBTCM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

BTCM has an Altman-Z score of -7.92. This is a bad value and indicates that BTCM is not financially healthy and even has some risk of bankruptcy.
BTCM's Altman-Z score of -7.92 is on the low side compared to the rest of the industry. BTCM is outperformed by 87.19% of its industry peers.
BTCM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -7.92
ROIC/WACCN/A
WACC11.4%
BTCM Yearly LT Debt VS Equity VS FCFBTCM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

BTCM has a Current Ratio of 1.70. This is a normal value and indicates that BTCM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.70, BTCM is in line with its industry, outperforming 54.09% of the companies in the same industry.
BTCM has a Quick Ratio of 1.70. This is a normal value and indicates that BTCM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.70, BTCM is in line with its industry, outperforming 54.80% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.7
BTCM Yearly Current Assets VS Current LiabilitesBTCM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1

3. Growth

3.1 Past

The earnings per share for BTCM have decreased strongly by -26.52% in the last year.
Looking at the last year, BTCM shows a very strong growth in Revenue. The Revenue has grown by 122.99%.
EPS 1Y (TTM)-26.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)122.99%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-15.51%

3.2 Future

Based on estimates for the next years, BTCM will show a very negative growth in Earnings Per Share. The EPS will decrease by -72.80% on average per year.
Based on estimates for the next years, BTCM will show a very negative growth in Revenue. The Revenue will decrease by -37.14% on average per year.
EPS Next Y-137.09%
EPS Next 2Y-90.53%
EPS Next 3Y-72.8%
EPS Next 5YN/A
Revenue Next Year-83.22%
Revenue Next 2Y-55.04%
Revenue Next 3Y-37.14%
Revenue Next 5YN/A

3.3 Evolution

BTCM Yearly Revenue VS EstimatesBTCM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
BTCM Yearly EPS VS EstimatesBTCM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2022 2023 2024 0 5 10

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 0.24, which indicates a rather cheap valuation of BTCM.
Compared to the rest of the industry, the Price/Earnings ratio of BTCM indicates a rather cheap valuation: BTCM is cheaper than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.67, BTCM is valued rather cheaply.
With a Price/Forward Earnings ratio of 26.85, BTCM can be considered very expensive at the moment.
67.26% of the companies in the same industry are more expensive than BTCM, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of BTCM to the average of the S&P500 Index (23.13), we can say BTCM is valued inline with the index average.
Industry RankSector Rank
PE 0.24
Fwd PE 26.85
BTCM Price Earnings VS Forward Price EarningsBTCM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BTCM is valued cheaper than 93.24% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.02
BTCM Per share dataBTCM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

A cheap valuation may be justified as BTCM's earnings are expected to decrease with -72.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-90.53%
EPS Next 3Y-72.8%

0

5. Dividend

5.1 Amount

No dividends for BTCM!.
Industry RankSector Rank
Dividend Yield N/A

BIT MINING LTD - SPON ADR

NYSE:BTCM (9/29/2025, 8:04:01 PM)

After market: 2.66 -0.01 (-0.37%)

2.67

+0.08 (+3.09%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-28 2025-02-28/amc
Earnings (Next)N/A N/A
Inst Owners3.33%
Inst Owner Change6.68%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap47.63M
Analysts43.33
Price TargetN/A
Short Float %165.27%
Short Ratio0.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-59.1%
Min Revenue beat(2)-70.77%
Max Revenue beat(2)-47.44%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 0.24
Fwd PE 26.85
P/S 1.45
P/FCF N/A
P/OCF N/A
P/B 0.84
P/tB 1.04
EV/EBITDA 8.02
EPS(TTM)11.1
EY415.73%
EPS(NY)0.1
Fwd EY3.72%
FCF(TTM)-1.9
FCFYN/A
OCF(TTM)-1.84
OCFYN/A
SpS1.85
BVpS3.19
TBVpS2.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 13.98%
ROE 21.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 36.67%
GM 9.07%
FCFM N/A
ROA(3y)-71.39%
ROA(5y)-56.06%
ROE(3y)-133.77%
ROE(5y)-97.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y179.81%
GM growth 5YN/A
F-Score5
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 8.89%
Cap/Sales 3.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.7
Quick Ratio 1.7
Altman-Z -7.92
F-Score5
WACC11.4%
ROIC/WACCN/A
Cap/Depr(3y)20.6%
Cap/Depr(5y)69.66%
Cap/Sales(3y)3%
Cap/Sales(5y)4.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y-137.09%
EPS Next 2Y-90.53%
EPS Next 3Y-72.8%
EPS Next 5YN/A
Revenue 1Y (TTM)122.99%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-15.51%
Revenue Next Year-83.22%
Revenue Next 2Y-55.04%
Revenue Next 3Y-37.14%
Revenue Next 5YN/A
EBIT growth 1Y73.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-13.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-15.24%
OCF growth 3YN/A
OCF growth 5YN/A